Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

Authors

Keywords

Journal

Volume Volume 4, Issue -, Pages 163-187

Publisher

Dove Medical Press Ltd.

Online

2016-10-31

DOI

10.2147/tcrm.s1527

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now